CS MCKEE LP - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 267 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 0.65 and the average weighting 0.2%.

Quarter-by-quarter ownership
CS MCKEE LP ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2019$798,000
-14.9%
33,650
-1.5%
0.07%
-14.1%
Q3 2019$938,000
-17.0%
34,1500.0%0.08%
-15.0%
Q2 2019$1,130,000
-8.3%
34,150
-2.8%
0.10%
-7.4%
Q1 2019$1,232,000
-1.2%
35,150
-6.4%
0.11%
-12.2%
Q4 2018$1,247,000
-33.7%
37,550
+0.5%
0.12%
-18.0%
Q3 2018$1,881,000
-15.8%
37,3500.0%0.15%
-20.6%
Q2 2018$2,235,000
+18.3%
37,350
-9.5%
0.19%
+27.7%
Q1 2018$1,889,000
+10.9%
41,250
-3.5%
0.15%
+16.5%
Q4 2017$1,704,000
-0.4%
42,7500.0%0.13%
-4.5%
Q3 2017$1,710,000
-5.6%
42,750
+1.7%
0.13%
-8.3%
Q2 2017$1,812,000
+38.3%
42,050
+0.5%
0.14%
+39.4%
Q1 2017$1,310,000
+22.8%
41,850
-0.9%
0.10%
+28.4%
Q4 2016$1,067,000
-5.6%
42,250
-7.5%
0.08%
+12.5%
Q3 2016$1,130,000
+7.5%
45,700
-11.4%
0.07%
+60.0%
Q2 2016$1,051,00051,6000.04%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q2 2017
NameSharesValueWeighting ↓
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 426,500$11,754,3403.96%
ASHFORD CAPITAL MANAGEMENT INC 916,747$25,274,7153.72%
ARMISTICE CAPITAL, LLC 5,092,000$140,386,4402.15%
S&T BANK/PA 215,578$5,9431.15%
Aristotle Capital Boston, LLC 1,187,981$32,752,6341.06%
RICE HALL JAMES & ASSOCIATES, LLC 544,468$15,010,9830.95%
Tributary Capital Management, LLC 352,429$9,716,4680.92%
Bridge City Capital, LLC 65,297$1,800,2380.91%
Integral Health Asset Management, LLC 220,000$6,065,4000.84%
Retirement Planning Co of New England, Inc. 51,608$1,422,8330.79%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders